Boston, Mass.; and Cincinnati, Ohio From the Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, and the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Cincinnati Medical Center.
Plast Reconstr Surg. 2011 Mar;127(3):1080-1085. doi: 10.1097/PRS.0b013e31820436cb.
Since the inception of microvascular free tissue transfer, flap monitoring has been based on clinical signs. Color, capillary refill, and handheld Doppler have been used for monitoring in the postoperative period; however, subjective clinical examination may delay recognition of flap compromise. Tissue oximeter monitoring offers an objective method for detecting vascular compromise with the measurement of tissue oxygen saturation and real-time flap perfusion.
The authors reviewed 614 consecutive microsurgical flaps for breast reconstruction from 2004 to 2010. The authors' first 380 patients underwent clinical flap postoperative monitoring. Starting in June of 2008, the authors used tissue oximetry as an adjunct on 234 consecutive patients. Flap reexploration, flap loss, salvage rate, fat necrosis, and characteristics of vascular compromise were analyzed.
There were 26 instances of flap reexploration (6.8 percent) and 11 flap losses (2.9 percent) before use of tissue oximetry. After tissue oximetry was used, there were 16 instances of flap reexploration (6.8 percent) and one flap loss. The rate of flap reexploration was not statistically significant between groups, but the difference between the flap failure rates is significant (p = 0.025). The flap salvage rate was previously 57.7 percent; after tissue oximetry monitoring, the flap salvage rate was 93.75 percent (p = 0.015).
The use of tissue oximetry has decreased the authors' flap loss rate and improved the flap salvage rate in microsurgical breast reconstruction. This device is a useful adjunct in flap monitoring during the postoperative period, as it may help decrease flap loss by detecting impending vascular compromise before it becomes clinically evident.
自微血管游离组织移植问世以来,皮瓣监测一直基于临床体征。在术后,颜色、毛细血管再充盈和手持多普勒均用于监测;然而,主观的临床检查可能会延迟发现皮瓣失代偿。组织血氧计监测通过测量组织氧饱和度和实时皮瓣灌注提供了一种检测血管失代偿的客观方法。
作者回顾了 2004 年至 2010 年期间进行的 614 例连续乳房重建显微外科皮瓣。作者的前 380 例患者接受了临床皮瓣术后监测。自 2008 年 6 月起,作者对 234 例连续患者使用组织血氧计作为辅助监测。分析皮瓣再探查、皮瓣丢失、成活率、脂肪坏死和血管失代偿的特征。
在使用组织血氧计之前,有 26 例皮瓣再探查(6.8%)和 11 例皮瓣丢失(2.9%)。使用组织血氧计后,有 16 例皮瓣再探查(6.8%)和 1 例皮瓣丢失。两组之间的皮瓣再探查率没有统计学意义,但皮瓣失败率的差异有统计学意义(p=0.025)。皮瓣成活率以前为 57.7%;使用组织血氧计监测后,皮瓣成活率为 93.75%(p=0.015)。
在显微乳房重建中,使用组织血氧计降低了作者的皮瓣失效率,提高了皮瓣成活率。该设备是术后皮瓣监测的有用辅助手段,因为它可以通过在临床明显之前检测到即将发生的血管失代偿,帮助减少皮瓣丢失。